[Therapeutic protection and limitation of the area of necrosis in acute myocardial infarct].
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005950:Glucose Solution, Hypertonic / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D005996:Nitroglycerin / Q000627:therapeutic use; D010102:Oxygen Inhalation Therapy; D013999:Timolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D005343:Fibrinolytic Agents; D005950:Glucose Solution, Hypertonic; D014665:Vasodilator Agents; D013999:Timolol; D005996:Nitroglycerin; D002994:Clofibrate
Terapia de protecţie şi limitare a zonei necroză în infarctul miocardic acut.